NovaBay Pharmaceuticals (NYSE:NBY) said its preliminary net revenue for the second quarter was $2.4 million, primarily driven by its eyecare products. Net revenue from the company’s eyecare products ...
Source LinkNovaBay Pharmaceuticals (NYSE:NBY) said its preliminary net revenue for the second quarter was $2.4 million, primarily driven by its eyecare products. Net revenue from the company’s eyecare products ...
Source Link
Comments